MetLife, Inc. (NYSE:MET) Holdings Increased by Entropy Technologies LP

Entropy Technologies LP lifted its stake in MetLife, Inc. (NYSE:MET) by 9.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 14,025 shares of the financial services provider’s stock after acquiring an additional 1,204 shares during the period. Entropy Technologies LP’s holdings in MetLife were worth $1,148,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also made changes to their positions in MET. MeadowBrook Investment Advisors LLC boosted its stake in MetLife by 244.4% during the 3rd quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. lifted its holdings in MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after acquiring an additional 186 shares during the last quarter. Wolff Wiese Magana LLC boosted its position in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 277 shares in the last quarter. Peterson Financial Group Inc. bought a new stake in shares of MetLife in the 3rd quarter worth approximately $30,000. Finally, Retirement Wealth Solutions LLC acquired a new stake in MetLife during the fourth quarter valued at approximately $32,000. Institutional investors and hedge funds own 94.99% of the company’s stock.

MetLife Trading Down 1.0 %

Shares of MET stock opened at $83.12 on Tuesday. MetLife, Inc. has a 12 month low of $67.04 and a 12 month high of $89.05. The company has a market cap of $57.55 billion, a PE ratio of 13.92, a price-to-earnings-growth ratio of 0.64 and a beta of 1.07. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.54. The business’s 50 day moving average is $83.72 and its two-hundred day moving average is $80.88.

MetLife (NYSE:MET) last released its earnings results on Wednesday, February 5th. The financial services provider reported $2.08 earnings per share for the quarter, missing analysts’ consensus estimates of $2.13 by ($0.05). MetLife had a return on equity of 20.42% and a net margin of 6.19%. Equities analysts predict that MetLife, Inc. will post 9.63 EPS for the current year.

MetLife Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 11th. Stockholders of record on Tuesday, February 4th will be issued a dividend of $0.545 per share. The ex-dividend date of this dividend is Tuesday, February 4th. This represents a $2.18 annualized dividend and a dividend yield of 2.62%. MetLife’s payout ratio is 36.52%.

Analysts Set New Price Targets

Several research analysts have issued reports on the company. Wells Fargo & Company dropped their price target on MetLife from $93.00 to $92.00 and set an “overweight” rating on the stock in a report on Tuesday, January 14th. JPMorgan Chase & Co. increased their price target on MetLife from $86.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Barclays cut their price objective on MetLife from $96.00 to $95.00 and set an “overweight” rating on the stock in a report on Friday. TD Cowen raised their target price on shares of MetLife from $97.00 to $99.00 and gave the stock a “buy” rating in a report on Wednesday, November 27th. Finally, BMO Capital Markets began coverage on shares of MetLife in a report on Thursday, January 23rd. They set a “market perform” rating and a $97.00 price target on the stock. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, MetLife currently has an average rating of “Moderate Buy” and an average target price of $91.08.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.